Revvity Gross Margin 2010-2024 | RVTY
Revvity Gross Margin Historical Data | |||
---|---|---|---|
Date | TTM Revenue | TTM Gross Profit | Gross Margin |
2024-09-30 | $2.72B | $1.51B | 55.44% |
2024-06-30 | $2.71B | $1.50B | 55.26% |
2024-03-31 | $2.73B | $1.51B | 55.50% |
2023-12-31 | $2.75B | $1.54B | 55.94% |
2023-09-30 | $2.80B | $1.59B | 56.94% |
2023-06-30 | $2.84B | $1.63B | 57.31% |
2023-03-31 | $3.02B | $1.78B | 58.73% |
2022-12-31 | $3.31B | $1.99B | 60.08% |
2022-09-30 | $3.00B | $2.00B | 66.48% |
2022-06-30 | $3.15B | $2.11B | 67.02% |
2022-03-31 | $3.48B | $2.24B | 64.45% |
2021-12-31 | $3.83B | $2.43B | 63.60% |
2021-09-30 | $3.63B | $2.44B | 67.18% |
2021-06-30 | $3.74B | $2.44B | 65.44% |
2021-03-31 | $3.32B | $2.21B | 66.47% |
2020-12-31 | $2.66B | $1.73B | 64.93% |
2020-09-30 | $3.23B | $1.68B | 51.96% |
2020-06-30 | $2.98B | $1.50B | 50.24% |
2020-03-31 | $2.89B | $1.40B | 48.35% |
2019-12-31 | $2.88B | $1.40B | 48.40% |
2019-09-30 | $2.84B | $1.37B | 48.47% |
2019-06-30 | $2.80B | $1.36B | 48.68% |
2019-03-31 | $2.78B | $1.36B | 48.74% |
2018-12-31 | $2.78B | $1.34B | 48.25% |
2018-09-30 | $2.66B | $1.27B | 47.73% |
2018-06-30 | $2.54B | $1.21B | 47.50% |
2018-03-31 | $2.39B | $1.13B | 47.17% |
2017-12-31 | $2.26B | $1.07B | 47.59% |
2017-09-30 | $2.18B | $1.04B | 47.85% |
2017-06-30 | $2.14B | $1.02B | 47.81% |
2017-03-31 | $2.13B | $1.02B | 47.86% |
2016-12-31 | $2.12B | $1.02B | 47.99% |
2016-09-30 | $2.00B | $0.96B | 48.02% |
2016-06-30 | $2.05B | $0.97B | 47.17% |
2016-03-31 | $2.08B | $0.97B | 46.48% |
2015-12-31 | $2.11B | $0.97B | 45.84% |
2015-09-30 | $2.10B | $0.95B | 45.39% |
2015-06-30 | $2.07B | $0.94B | 45.27% |
2015-03-31 | $2.07B | $0.93B | 45.21% |
2014-12-31 | $2.07B | $0.94B | 45.17% |
2014-09-30 | $2.22B | $1.00B | 45.22% |
2014-06-30 | $2.20B | $0.99B | 45.18% |
2014-03-31 | $2.18B | $0.99B | 45.21% |
2013-12-31 | $2.16B | $0.98B | 45.25% |
2013-09-30 | $2.13B | $0.96B | 45.05% |
2013-06-30 | $2.12B | $0.96B | 45.21% |
2013-03-31 | $2.10B | $0.96B | 45.48% |
2012-12-31 | $2.11B | $0.96B | 45.68% |
2012-09-30 | $2.08B | $0.94B | 45.20% |
2012-06-30 | $2.03B | $0.91B | 44.89% |
2012-03-31 | $1.98B | $0.88B | 44.35% |
2011-12-31 | $1.92B | $0.85B | 44.16% |
2011-09-30 | $1.85B | $0.82B | 44.20% |
2011-06-30 | $1.81B | $0.80B | 44.32% |
2011-03-31 | $1.76B | $0.78B | 44.62% |
2010-12-31 | $1.70B | $0.76B | 44.54% |
2010-09-30 | $1.54B | $0.71B | 45.99% |
2010-06-30 | $1.49B | $0.69B | 46.15% |
2010-03-31 | $1.51B | $0.69B | 45.59% |
2009-12-31 | $1.55B | $0.70B | 45.29% |
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Services | $13.634B | $2.751B |
Revvity Inc. provides products, services and solutions to the diagnostics, life sciences and applied services markets worldwide. Its operating segment includes Discovery & Analytical Solutions and Diagnostics. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Discovery & Analytical Solutions segment provides instruments, reagents, informatics, software, subscriptions, detection and imaging technologies. Revvity Inc., formerly known as PerkinElmer Inc., is based in Waltham, Massachusetts. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Elevance Health (ELV) | United States | $93.361B | 11.58 |
Cencora (COR) | United States | $48.280B | 17.81 |
DiDi Global (DIDIY) | China | $22.212B | 0.00 |
Natera (NTRA) | United States | $22.082B | 0.00 |
ICON (ICLR) | Ireland | $17.675B | 15.74 |
Viatris (VTRS) | United States | $15.958B | 4.92 |
Avantor (AVTR) | United States | $14.143B | 21.20 |
CochLear (CHEOY) | Australia | $12.777B | 0.00 |
Solventum (SOLV) | United States | $12.233B | 0.00 |
BioMerieux (BMXMF) | France | $11.895B | 0.00 |
Medpace Holdings (MEDP) | United States | $10.498B | 29.58 |
Charles River Laboratories (CRL) | United States | $10.011B | 19.34 |
HealthEquity (HQY) | United States | $9.104B | 49.41 |
Doximity (DOCS) | United States | $8.999B | 52.97 |
Sonic Healthcare (SKHHY) | Australia | $8.862B | 0.00 |
Bausch + Lomb (BLCO) | Canada | $6.892B | 32.08 |
Life Times (LTH) | United States | $5.081B | 33.63 |
Organon (OGN) | United States | $3.935B | 3.97 |
Sotera Health (SHC) | United States | $3.631B | 19.42 |
BrightSpring Health Services (BTSG) | United States | $3.265B | 69.44 |
Surgery Partners (SGRY) | United States | $2.925B | 33.35 |
Concentras Parent (CON) | United States | $2.789B | 0.00 |
PACS (PACS) | United States | $2.515B | 0.00 |
Alignment Healthcare (ALHC) | United States | $2.310B | 0.00 |
Ardent Health Partners (ARDT) | United States | $2.259B | 0.00 |
Premier (PINC) | United States | $2.195B | 11.42 |
GeneDx Holdings (WGS) | United States | $2.162B | 0.00 |
Ryman Healthcare (RYHTY) | New Zealand | $1.995B | 0.00 |
GoodRx Holdings (GDRX) | United States | $1.868B | 49.00 |
Teladoc Health (TDOC) | United States | $1.828B | 0.00 |
Progyny (PGNY) | United States | $1.315B | 26.62 |
Pediatrix Medical (MD) | United States | $1.285B | 12.57 |
CareDx (CDNA) | United States | $1.241B | 0.00 |
Establishment Labs Holdings (ESTA) | $1.206B | 0.00 | |
AMN Healthcare Services Inc (AMN) | United States | $0.984B | 6.66 |
Embecta (EMBC) | United States | $0.797B | 5.32 |
QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
Agilon Health (AGL) | United States | $0.779B | 0.00 |
SBC Medicals (SBC) | United States | $0.674B | 0.00 |
InnovAge Holding (INNV) | United States | $0.662B | 0.00 |
Auna S.A (AUNA) | Luxembourg | $0.522B | 0.00 |
Sonida Senior Living (SNDA) | United States | $0.474B | 0.00 |
DocGo (DCGO) | United States | $0.434B | 16.35 |
Enhabit (EHAB) | United States | $0.380B | 32.87 |
COMPASS Pathways (CMPS) | United Kingdom | $0.302B | 0.00 |
ModivCare (MODV) | United States | $0.254B | 13.79 |
LifeMD (LFMD) | United States | $0.251B | 0.00 |
Sera Prognostics (SERA) | United States | $0.221B | 0.00 |
Biodesix (BDSX) | United States | $0.186B | 0.00 |
Nutex Health (NUTX) | United States | $0.179B | 0.00 |
Beauty Health (SKIN) | United States | $0.176B | 0.00 |
MultiPlan (MPLN) | United States | $0.112B | 0.00 |
So-Young (SY) | China | $0.086B | 16.60 |
Ascend Wellness Holdings (AAWH) | United States | $0.085B | 0.00 |
Singular Genomics Systems (OMIC) | United States | $0.054B | 0.00 |
OncoCyte (OCX) | United States | $0.046B | 0.00 |
NeueHealth (NEUE) | United States | $0.041B | 1.10 |
IceCure Medical (ICCM) | Israel | $0.032B | 0.00 |
Co-Diagnostics (CODX) | United States | $0.032B | 0.00 |
Pheton Holdings (PTHL) | China | $0.031B | 0.00 |
NeuroOne Medical Technologies (NMTC) | United States | $0.021B | 0.00 |
Oncology Institute (TOI) | United States | $0.012B | 0.00 |
SeaStar Medical Holding (ICU) | United States | $0.009B | 0.00 |
XWELL (XWEL) | United States | $0.008B | 0.00 |
Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
KindlyMD (KDLY) | United States | $0.006B | 0.00 |
BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
ISpecimen (ISPC) | United States | $0.004B | 0.00 |
NewGenIvf Group (NIVF) | Thailand | $0.002B | 0.00 |
Aclarion (ACON) | United States | $0.002B | 0.00 |
Cano Health (CANOQ) | United States | $0.001B | 0.00 |